Published in Antibiot Med Biotekhnol on January 01, 1985
Electric field effect in atomically thin carbon films. Science (2004) 45.10
Two-dimensional gas of massless Dirac fermions in graphene. Nature (2005) 22.35
Nanofabricated media with negative permeability at visible frequencies. Nature (2005) 2.08
Quantitative analysis of antimicrobial effect kinetics in an in vitro dynamic model. Antimicrob Agents Chemother (1990) 1.53
[Cyclosporin biosynthesis and dynamics of bioenergetic processes in cyclosporin-producing strain]. Antibiot Khimioter (1990) 1.39
[Interaction of taxifolin (dihydroquercetin) with dimyristoylphosphatidylcholine multilamellar liposomes]. Biofizika (2008) 1.29
A dynamic model for in-vitro evaluation of antimicrobial action by simulation of the pharmacokinetic profiles of antibiotics. J Antimicrob Chemother (1989) 0.99
[Kinetics of the antimicrobial effect in a dynamic system: the microcalorimetric recording method and choice of parameters for characterizing kinetic curves]. Antibiot Med Biotekhnol (1985) 0.85
Comparative pharmacodynamics of gatifloxacin and ciprofloxacin in an in vitro dynamic model: prediction of equiefficient doses and the breakpoints of the area under the curve/MIC ratio. Antimicrob Agents Chemother (2000) 0.82
[Principles for analyzing the kinetic curves of the antimicrobial effect in dynamic systems simulating the pharmacokinetic profiles of antibiotics]. Antibiot Med Biotekhnol (1987) 0.81
Age dependence of erythromycin rectal bioavailability in children. Eur J Drug Metab Pharmacokinet (1991) 0.81
Interference phenomena and long-range proximity effect in clean superconductor-ferromagnet systems. Phys Rev Lett (2012) 0.80
[Correlation between pharmacokinetic parameters of rifampicin and its biologically active metabolite as related to estimation of the relative bioavailability of the antibiotic]. Antibiot Khimioter (1996) 0.79
[Cloning and study of the structure of erythromycin biosynthesis and resistance gene cluster in Streptomyces erythraeus]. Dokl Akad Nauk SSSR (1990) 0.78
The antistaphylococcal pharmacodynamics of linezolid alone and in combination with doxycycline in an in vitro dynamic model. J Chemother (2011) 0.77
[Aminoglycoside-3'-phosphotransferase from Actinomyces fradiae. Its isolation, purification and properties]. Antibiotiki (1979) 0.77
The pharmacodynamics of gatifloxacin and ciprofloxacin for pneumococci in an in vitro dynamic model: prediction of equiefficient doses. J Antimicrob Chemother (2001) 0.76
[Pharmacology of rifampicin]. Antibiotiki (1977) 0.76
Polymorphism of heterochromatin areas on chromosomes 1, 9, 16 and Y in long-lived subjects and persons of different ages in two regions of the Soviet Union. Arch Gerontol Geriatr (1987) 0.76
[DNA cloning in actinomycetes: the creation of vector systems]. Antibiotiki (1984) 0.75
[Aclacinomycin A: a new antitumor antibiotic]. Antibiotiki (1982) 0.75
[Comparative in vitro study of antibiotic resistance increase in classical cholera and E1 Tor vibrios]. Antibiotiki (1971) 0.75
[Role of plasmid genes in neomycin synthesis]. Antibiotiki (1981) 0.75
[Chemotherapeutic study of antibiotics]. Antibiotiki (1967) 0.75
Effects of haemodialysis on dynamics of some antibiotics in blood of patients with kidney insufficiency complicated by purulent infection. Bull Soc Int Chir (1972) 0.75
[Antiviral properties of analogs of distamycin A]. Antibiotiki (1977) 0.75
[Formation and development of the science and manufacture of antibiotics in the USSR]. Antibiotiki (1977) 0.75
[Peculiarities of ampicillin use in acute renal failure]. Antibiotiki (1971) 0.75
[Induced tolerance to antitumor effect of bacterial polysaccharides]. Antibiotiki (1965) 0.75
[Significance of concentration of ampicillin in the treatment of surgical patients]. Antibiotiki (1970) 0.75
[Experimental studies on the antiviral effect of distamycin A]. Antibiotiki (1973) 0.75
[Development of a method for the quantitative assessment of the microorganism sensitivity to antibiotics by using discs. A study of the patterns of doxycycline diffusion from discs into the nutrient agar]. Antibiotiki (1977) 0.75
[Characteristics of current antibiotic therapy]. Klin Med (Mosk) (1979) 0.75
[C-14 fusidin levels in mice following single intravenous administration]. Antibiotiki (1971) 0.75
[Specificity of interaction of F-pili of donor bacteria with recipient bacteria in conjugation in E. coli]. Antibiotiki (1973) 0.75
[Results of an experimental study of the antitumor activity of 1-asparaginase from E. coli and Erw. carotovora]. Antibiotiki (1977) 0.75
[Antibiotics and the macroorganism (the causes and the mechanism of occurrence of side effects]. Antibiotiki (1977) 0.75
[Combined effect of semi-synthetic penicillins (ampicillin and oxacillin) on clinical strains of gram-positive and gram-negative microorganisms]. Antibiotiki (1969) 0.75
[Antiviral properties of fucidin]. Antibiotiki (1971) 0.75
[beta-lactamase inhibitors]. Antibiotiki (1980) 0.75
[Effect of rifampicin on the reproduction of DNA containing viruses in tissue culture cells]. Antibiotiki (1971) 0.75
[Peculiarities of transplacental penetration of fusidin in various periods of pregnancy]. Antibiotiki (1973) 0.75
[Study of ampicillin absorption in patients with chronic kidney failure]. Antibiotiki (1971) 0.75
[Directed isolation of Micromonospora generic cultures from moist soils and silts]. Antibiotiki (1978) 0.75
[Experimental study on the effect of fusidin on vaccine poxvirus]. Antibiotiki (1973) 0.75
[Antibiotics. The results and developmental prospects of the problem]. Izv Akad Nauk SSSR Biol (1978) 0.75
[Achievements in the field of obtaining and studying new semisynthetic cephalosporin antibiotics. Research in the field of directed cephalosporin synthesis]. Antibiotiki (1981) 0.75
[Formation of colonies of P-388 leukemic cells in semisolid agar]. Biull Eksp Biol Med (1978) 0.75
[Comparative sensitivity to cephaloridine and semisynthetic penicillins of causative agents in purulent infections]. Antibiotiki (1972) 0.75
[Study of the action of antitumor compounds on primary explants from human tumors]. Antibiotiki (1967) 0.75
[Microbiological and chemotherapeutic study of the antibiotic mutabilicin]. Antibiotiki (1967) 0.75
[Experimental study of the antiviral activity of distamycin A. (Preliminary note)]. G Mal Infett Parassit (1972) 0.75
[Use of different modifications of human cell culture method in the study of antineoplastic antibiotics]. Antibiotiki (1966) 0.75
[Mutants of Escherichia coli F--with changed recipient capacity]. Antibiotiki (1973) 0.75
[Rifampicin action on the ultrastructure of E. coli cells]. Antibiotiki (1978) 0.75
[Changes in microorganism sensitivity to antibiotics as affected by divalent metal ions]. Antibiotiki (1981) 0.75
[Experimental study of D-penicillamine]. Antibiotiki (1969) 0.75
[The sensitivity of human kidney cancer in cultures to antitumor preparations]. Vopr Onkol (1971) 0.75
[Selection of an optimal kanamycin treatment plan in experimental peritonitis in rats]. Antibiotiki (1972) 0.75
[Surgical infection: etiology and methods of antibiotic therapy]. Sov Med (1971) 0.75
[Diagnostic and therapeutic problems of infections caused by nonsporulating Gram-negative anaerobes]. Antibiotiki (1982) 0.75
[Efficacy of fucidin in surgical cases]. Antibiotiki (1972) 0.75
[Fusidin and its properties]. Antibiotiki (1967) 0.75
[Comparative experimental study of ceporin and oxacillin]. Antibiotiki (1970) 0.75
[Some problems of rational antibiotic therapy]. Sov Med (1968) 0.75
[Current antibiotic therapy of acute pneumonias and their complications]. Ter Arkh (1979) 0.75
[Combined effect of distamycin A and rifampicin on vaccinia virus in tissue culture cells]. Antibiotiki (1973) 0.75
[Pharmacokinetics and biotransformation of rifamycins in the body of experimental animals]. Antibiotiki (1979) 0.75
[A comparative study of the biological action of the polysaccharides glucan and laminarin]. Biull Eksp Biol Med (1966) 0.75
[Methodological approaches to controlling the antibiotic content in disks for determining microorganism antibiotic sensitivity]. Antibiotiki (1982) 0.75
[Study of the sensitivity of polyresistant strains of microbial causative agents of purulent infections to kanamycin sulfate]. Antibiotiki (1968) 0.75
[Characteristics of absorption and excretion of kanamycin in chronic renal insufficiency]. Antibiotiki (1973) 0.75
[New antibiotics in the treatment of surgical infection: the importance and principles of choice]. Vestn Akad Med Nauk SSSR (1979) 0.75
[Comparative evaluation of some methods for primary screening of antineoplastic antibiotics in vitro]. Antibiotiki (1970) 0.75
[Comparative study of methicillin and oxacillin in experimental conditions]. Antibiotiki (1967) 0.75
[Effects of antibiotics of the aureolic acid group and dactinomycin on human tumors in tissue culture]. Antibiotiki (1971) 0.75
[Experimental study of the antineoplastic effect of the antibiotic polymycin]. Antibiotiki (1970) 0.75
[Comparative experimental study of ceporin and ampicillin]. Antibiotiki (1970) 0.75
[Doxycycline and methacycline, some peculiarities of chemotherapeutic effect and pharmacokinetics]. Antibiotiki (1971) 0.75
[Study of the effect of chemotherapeutic compounds on El-Tor vibrios in experiments in vitro]. Antibiotiki (1970) 0.75
[Comparative effectiveness of combination of kanamycin with some antibiotics of broad spectrum activity in relation to gram-negative microorganisms]. Antibiotiki (1969) 0.75
[Comparative experimental antitumor activity of the antibiotics variamycin and mitramycin]. Antibiotiki (1978) 0.75
[Antitumor activity of fatty acid derivatives isolated from protozoa]. Antibiotiki (1977) 0.75
[Properties of aminoglycoside-3'-phosphotransferases determined by kanamycin transposones Tn 601 and Tn 5]. Biokhimiia (1980) 0.75
[Combined experimental use of polysynthetic penicillins]. Antibiotiki (1970) 0.75
[Absorption, distribution and excretion of fucidin in the body of animals]. Antibiotiki (1971) 0.75
[Mechanisms of enzymatic inactivation of aminoglycoside antibiotics by clinically semi-resistant strains of E. coli]. Antibiotiki (1974) 0.75
[Achievements and future developments in research on and manufacture of antibiotics]. Antibiotiki (1972) 0.75
[Kanamycin kinetics in acute kidney insufficiency]. Antibiotiki (1972) 0.75
[Peculiarities in the distribution of oxacillin and some of its derivatives in the body]. Antibiotiki (1967) 0.75
[Use of benzylpenicillin in the treatment of Proteus infections]. Antibiotiki (1971) 0.75
[Comparative effectiveness of gentamycin and other antibiotics in experiment]. Antibiotiki (1969) 0.75
[Action of rifampicin on the ultrastructure of Staphylococcus cells]. Antibiotiki (1977) 0.75
[Study of sensitivity of clinical strains of microorganisms to ampicillin and other broad spectrum antibiotics]. Antibiotiki (1969) 0.75
[Nonpolyene macrolide antibiotics]. Antibiotiki (1981) 0.75